Innovative early-stage businesses share £25m of funding

Linda Hanna, Interim CEO of Scottish Enterprise

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

GRANT and investment funding of almost £25 million has been committed to 90 innovative, early-stage businesses in Scotland whose growth ambitions were impacted by the onset of the covid-19 pandemic.

The awards have been made via the Early Stage Growth Challenge Fund, part of a £38m package of early-stage support announced by the Scottish Government in July.

The fund, managed by Scottish Enterprise (SE), was established to help Scotland’s most promising emerging businesses continue to innovate through the pandemic.

Economy Secretary Fiona Hyslop said: “The energy and ideas of Scotland’s entrepreneurs and innovators have always fuelled the nation’s economic growth, creating high-value jobs and accelerating international investment in Scotland.

“However, we recognise that these businesses are not immune to the impact of the pandemic. Many are facing a challenging investment market which restricts their ability to grow, innovate and compete internationally.

“Our investment of £38 million will provide young and innovative businesses in some of our most exciting emerging sectors, such as life sciences, digital technologies and space, with the most comprehensive and generous support available anywhere in the UK.”

Scottish Enterprise Interim CEO Linda Hanna said: “There was concern among Scotland’s early-stage ecosystem that the coronavirus pandemic would cause investment levels to reduce dramatically, potentially wiping out a generation of Scotland’s up-and-coming businesses.

“The creation of the early-stage support package, developed by Scottish Enterprise on behalf of the Scottish Government, has proved to be an important intervention.

“Through the Early Stage Growth Challenge Fund, we’ve been able to provide several of Scotland’s most pioneering young companies with the financial support necessary to overcome obstacles to growth created by covid-19.”

Companies awarded funding include:

Oban-based biotechnology company CuanTec, which is developing a sustainable alternative to single-use plastic from food waste extract alongside the Scottish Association of Marine Science.

CuanTec CEO Craig Sterling said: “This is a critical time in our development. The Early Stage Growth Challenge Fund support will allow us to push forward and attract further funding to get our first sustainable food packaging product to market.”

Dundee tech company Snappy Shopper, which aims to revolutionise and revitalise the community-based convenience retail industry. Snappy Shopper Chairman Sean Collins said: “Our investment plans were delayed by COVID-19, but being awarded Early Stage Growth Challenge Fund support ensures we can continue our current incredible sales growth, strengthen our team with professional, high-quality people and invest heavily in our expansion into the rest of the UK.”

Glasgow-based space engineering company Craft Prospect. Craft Prospect Managing Director Steve Greenland said: “The Early Stage Growth Challenge Fund will be transformational for Craft Prospect, allowing the business to invest in a number of high-profile opportunities to grow our commercial offering internationally over the next two years, and providing us with the confidence to recruit and upskill our workforce despite the ongoing impacts of covid.”

Edinburgh-based consumer protection software company Vistalworks. Vistalworks CEO Vicky Brock said: “We’re incredibly grateful to the Scottish Investment Bank and the Scottish Government for their Early Stage Growth Challenge fund investment. This has been transformational at a point when the business was ready for acceleration. We’re already executing our plans and have taken on four new employees as a direct result, with more to follow.”

Lanarkshire-based biotechnology company ILC Therapeutics, which is working with leading academic institutions including the University of St Andrews and the University of Oxford to develop therapeutic products addressing diseases and conditions including covid-19, cancer, atopic dermatitis and asthma. Dr Christopher McKenzie, senior scientist at ILC Therapeutics, said: “The Early Stage Growth Challenge Fund will allow us to continue developing novel therapeutics by allowing us to increase lab space and double our scientific team.”

Proteus, the cloud-based operating platform developed by Aberdeen-based tech firm Xergy. Xergy COO Niger Filer said: “As a start-up business the support provided by the Early Stage Growth Challenge Fund is invaluable in helping to make up for delayed revenues and allow us to continue to evolve our software platform and execute our sales and marketing plan to take our Proteus platform to market.”

In addition to the Early Stage Growth Challenge Fund, the early-stage support programme comprised £3m for pre-seed start-up companies and spin-out projects, and £10m for SE’s existing co-investment funds.

Facebook
Twitter
LinkedIn

Related News

Our brands